Post Marketing Surveillance of Roflumilast in Korea

Status:
Completed

Trial end date:
2017-04-26

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the safety and efficacy of roflumilast in the real-use conditions with its registered indications.

AstraZeneca